MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Copper"

  • 2024 International Congress

    Wilson Disease Presenting as Rapidly Progressive Dementia

    V. Chang, E. Brown (San Francisco, USA)

    Objective: To describe an atypical presentation of Wilson Disease. Background: Wilson Disease is a rare autosomal recessive disorder that causes copper accumulation in the brain…
  • 2024 International Congress

    A Curious Case of Copper de-Compensation

    D. Tang, CH. Tan, SF. Woo, D. Soon, J. Tan (Singapore, Singapore)

    Objective: To describe the investigation and management of a patient with Wilson’s disease who experienced late-onset neurological deterioration despite continued treatment. Background: Wilson’s disease is…
  • 2024 International Congress

    Increased Brain-Age Gap Estimate (BrainAGE) in Neurological Wilson Disease

    A. Hausmann, J. Caspers, S. Kannenberg, S. More, K. Patil, A. Schnitzler, C. Rubbert, C. Hartmann (Duesseldorf, Germany)

    Objective: To assess grey matter (GM) volume derived brain-aging in Wilson Disease (WD) using a previously proposed machine learning (ML) algorithm. Background: GM atrophy is…
  • 2023 International Congress

    Wilson disease: a single-center study from Tunisia

    R. Zouari, R. Amouri, I. Ben Kraiem, MZ. Saeid, F. Nabli, S. Ben Sassi (Tunis, Tunisia)

    Objective: We aimed to describe different clinical and radiological presentations of WD and insist on the necessity of early diagnosis to ensure therapeutic efficiency. Background:…
  • 2023 International Congress

    Minimum clinically important difference (MCID) on the Unified Wilson Disease Rating Scale (UWDRS) Part III: results from the Phase 3 FoCus Trial

    T. Litwin, A. Czlonkowska, P. Hedera, J. Bronstein, M. Lorincz, M. Møller, G. Wegmann, G. Carron, A. Messali, A. Poujois (Warsaw, Poland)

    Objective: Minimum clinically important differences (MCID) on the Unified Wilson Disease Rating Scale (UWDRS) Part III were estimated using data from a phase III trial…
  • 2023 International Congress

    Idiopathic Intracranial Hypertension as the presenting symptom in Wilson’s Disease: how is it possible?

    V. Mesquita, F. Rolim, A. Gomes, R. Carvalho, P. Matos, A. Marinho, N. Frota, F. Carvalho (Fortaleza, Brazil)

    Objective: To report a patient with Wilson’s disease (WD) who became symptomatic shortly after presenting Idiopathic Intracranial Hypertension (HII). Background: WD’s pleomorphic clinical phenotype remains…
  • 2022 International Congress

    WHODAS 2.0 to access functional disabilities of Wilson disease’s patients

    P. Ribeiro, E. Silva, F. Nery, H. Miranda, I. Pedroto, J. Ferreira, J. Gandara, L. Maia, P. Fernandes, S. Ferreira, M. Magalhães (Matosinhos, Portugal)

    Objective: We aim to analyze the disability status of WD patients by using the World Health Organization Disability Assessment Schedule 2.0 scale (WHODAS 2.0) and…
  • 2022 International Congress

    Epidemiological, clinical and paraclinical characteristics of metals accumulation in brain in childhood

    A. Atrous, H. Ben Rhouma, Z. Miladi, T. Ben Younes, H. Klaa, I. Kraoua, I. Benyoussef Turki (Ariana, Tunisia)

    Objective: The aim of our study is to describe epidemiological, clinical, and paraclinical characteristics of metals accumulation in brain in children. Background: Movement disorders can…
  • 2022 International Congress

    Lentiform fork sign and Wilson Disease

    JL. Freitas, MS. Rocha, PC. Matos, I. Torres, L. Corazza, JF. Tasch (São Paulo, Brazil)

    Objective: First description of lentiform fork sign in patients with the diagnosis of Wilson disease. Background: Lentiform fork sign is a rare neuroradiological sign characterized…
  • MDS Virtual Congress 2021

    D-penicillamine induced lupus erythematosus – the complication of Wilson’s disease treatment – a case report.

    A. Antos, T. Litwin, A. Przybyłkowski, M. Skowrońska, I. Kurkowska-Jastrzębska, A. Członkowska (Warsaw, Poland)

    Objective: Wilson’s disease (WD) is an inherited disorder of copper metabolism with copper accumulation in different organs and clinical symptoms related to the affected organs…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley